🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07653659
Recruiting Observational

Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in Distributive Shock

NCT07653659 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College Hospital
Phase
Observational
Started
2025-09-01
Last updated
2026-06-17

Condition(s) studied

Distributive ShockHemodynamic AssessmentCritical Illness

Investigational drug(s) / intervention(s)

Not applicable- observational study

Not applicable- observational study: Observation of hemodynamic parameters before and after clinically indicated norepinephrine dose reduction. No investigator-initiated intervention was performed.

Study summary

This study prospectively observes changes in critical closing pressure (Pcc) and derived hemodynamic parameters in mechanically ventilated distributive shock patients when clinically indicated norepinephrine dose reduction is performed by the attending physician. Pcc is measured before and 30 minutes after dose reduction using a stepwise inspiratory hold maneuver via PiCCO monitoring.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Adult distributive shock patients aged ≥18 years; 2. Receiving norepinephrine infusion with MAP in the 75-85 mmHg range; 3. PiCCO catheter in situ; 4. Under mechanical ventilation; 5. Clinically indicated norepinephrine dose reduction per attending physician judgment. Exclusion Criteria: 1. Significant cardiac arrhythmia affecting CO measurement reliability; 2. Contraindication to airway plateau pressure maneuver; 3. Active titration of other vasoactive agents within 30 minutes prior to measurement; 4. Hemodynamic instability making it impossible to reduce norepinephrine dose.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking Union Medical College Hospital Beijing Beijing Municipality Recruiting

More Peking Union Medical College Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07653659 on ClinicalTrials.gov ↗ ← All trials in China